TYMS and non-small cell lung carcinoma: A recent meta-analysis that evaluated the predictive value of TS in pemetrexed-containing chemotherapy regimens for NSCLC patients suggests that increased levels of TS are an independent risk factor for potential resistance against pemetrexed [10].